Gender-specific drugs are those exclusively indicated for either male or female patients.
HMSA's point-of-sale gender edit results in denial of claims submitted for drugs dispensed to patients of the “wrong” gender.
The edit assists HMSA in maintaining benefit integrity for non-covered drugs.
Following is a list of gender-specific drugs, subject to change, which are currently affected by this edit.
Exclusive Male Drugs
- Erectile Dysfunction
- Testosterone – all forms
Exclusive Female Drugs
- Infertility
- Estrogen – all forms
- Contraception – all forms
Revision History
| Date | Nature of Revision |
|---|---|
| 08/03/2026 | Migrated to new platform. |